3-乙酰基-2-甲基-6-(三氟甲基)吡啶 | 205582-83-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-乙酰基-2-甲基-6-(三氟甲基)吡啶
• 英文名称: 3-Acetyl-2-methyl-6-(trifluoromethyl)pyridine
• 英文别名: 1-[2-methyl-6-(trifluoromethyl)pyridin-3-yl]ethanone
• CAS: 205582-83-8
• 化学式: C₉H₈F₃NO
• mdl: MFCD03407376
• 分子量: 203.16
• InChiKey: SLRPZQQYFZSWBO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• PYRIDYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION
  申请人：ZHANG Yan

  公开号：US20120129843A1

  公开（公告）日：2012-05-24

  This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables R z , Q, J, R 1 , R 3 , R 5 , and R 6 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

  这项发明涉及噻唑I及其治疗和预防用途，其中变量Rz、Q、J、R1、R3、R5和R6在规范中有定义。治疗和/或预防的疾病包括类风湿关节炎。
• ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
  申请人：Pajouhesh Hassan A.

  公开号：US20120245137A1

  公开（公告）日：2012-09-27

  Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity, are disclosed. Specifically, a series of compounds containing aryl sulphone derivatives, as exemplified by Formula (I).

  本发明揭示了对于以不需要的钙通道活性，特别是不需要的N型和/或T型钙通道活性为特征的情况，有效改善的方法和化合物。具体地，本发明揭示了一系列含有芳基磺酰衍生物的化合物，例如公式（I）所示。
• BISARYLSULFONE AND DIALKYLARYLSULFONE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS
  申请人：Pajouhesh Hassan A.

  公开号：US20140113898A1

  公开（公告）日：2014-04-24

  The invention relates to bisarylsulfone and dialkylarylsulfone compounds (e.g., compounds according to any of Formulas (I)-(IX) or compounds (1)-(227) of Tables 4 and 5) useful in treating conditions associated with calcium channel function, and particularly conditions associated with N-type calcium channel activity. The invention also relates to pharmaceutical compositions that include these bisarylsulfone compounds, as well methods for the treatment of conditions such as cardiovascular disease, epilepsy, cancer and pain.

  本发明涉及双芳基砜和二烷基芳基砜化合物（例如，根据任何公式（I）-（IX）或表4和5的化合物（1）-（227）的化合物），其可用于治疗与钙通道功能有关的疾病，特别是与N型钙通道活性有关的疾病。本发明还涉及包括这些双芳基砜化合物的制药组合物，以及用于治疗心血管疾病、癫痫、癌症和疼痛等疾病的方法。
• Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
  申请人：Fisher Raymond

  公开号：US20090137558A1

  公开（公告）日：2009-05-28

  The present invention relates to substituted pyridine compounds of Formula (I) and derivatives thereof, and to a process for preparing these substituted pyridines. The invention also relates to the use of the substituted pyridines as intermediates in the production of pharmaceutical, chemical and agro-chemical products.

  本发明涉及式（I）的取代吡啶化合物及其衍生物，以及制备这些取代吡啶的过程。本发明还涉及将这些取代吡啶作为制药、化学和农业化学产品生产中间体的用途。
• PYRIDINE BASED COMPOUNDS USEFUL AS INTERMEDIATES FOR PHARMACEUTICAL OR AGRICULTURAL END-PRODUCTS
  申请人：Peakdale Molecular Limited

  公开号：EP1824828A2

  公开（公告）日：2007-08-29